Induced pluripotent stem-cell-derived cardiomyocytes: cardiac applications, opportunities, and challenges

Adrien Moreau1, Mohamed Boutjdir2, Mohamed Chahine1,3

  • 1a Centre de recherche de l'Institut universitaire en santé mentale de Québec, Quebec City, QC G1J 2G3, Canada.

Insights

Human induced pluripotent stem cells (hiPSCs) offer a powerful tool for studying chronic cardiovascular diseases. Patient-specific hiPSC-derived cardiomyocytes (hiPSC-CMs) allow investigation of genetic variants in cardiac disorders.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Genetics

Background:

  • Chronic diseases, particularly cardiovascular diseases, are leading causes of mortality globally.
  • Understanding the molecular mechanisms of these diseases is crucial for developing effective treatments.
  • Traditional genetic screening methods often fail to identify causative mutations in cardiac disorders.

Purpose of the Study:

  • To review the current knowledge on human induced pluripotent stem cells (hiPSCs) and their derived cardiomyocytes (hiPSC-CMs).
  • To discuss the potential, limitations, and challenges of using hiPSC-CMs in disease modeling.
  • To explore future prospects of hiPSC-CM technology in cardiovascular research.

Main Methods:

  • Review of existing literature on hiPSC technology and its application in cardiovascular disease research.
  • Focus on patient-specific hiPSC-derived cardiomyocytes (hiPSC-CMs) for disease modeling.
  • Analysis of the potential and limitations of hiPSC-CMs for investigating genetic variants.

Main Results:

  • hiPSC technology enables the creation of patient-specific cell models for studying complex diseases.
  • hiPSC-CMs provide a unique in vitro environment to investigate genetic variants in cardiovascular disorders.
  • The review highlights the significant potential of hiPSC-CMs while acknowledging current limitations and challenges.

Conclusions:

  • hiPSC-CMs represent a promising platform for advancing our understanding of cardiovascular diseases.
  • This technology facilitates the study of patient-specific genetic variations in a relevant biological context.
  • Further development is needed to overcome limitations and fully realize the potential of hiPSC-CMs in clinical applications.

Related Concept Videos